5

Active Studies

3

Recruiting

2

Phase 3

5

Top Sponsors

4

Changes, 30 Days

What Changed in the Last 30 Days

Detected	Trial	Change
2026-05-14	NCT03808610 Low-Intensity Chemotherapy and Venetoclax in Treating Patients With Relapsed or…	Trial terminated
2026-05-14	NCT03808610 Low-Intensity Chemotherapy and Venetoclax in Treating Patients With Relapsed or…	critical why stopped: null → "\\<75% participation"
2026-05-14	NCT03808610 Low-Intensity Chemotherapy and Venetoclax in Treating Patients With Relapsed or…	date change Primary completion moved earlier: 2026-12-31 -> 2026-05-05
2026-05-14	NCT03808610 Low-Intensity Chemotherapy and Venetoclax in Treating Patients With Relapsed or…	date change Completion moved earlier: 2026-12-31 -> 2026-05-05

Active Studies by Phase

Phase 3

1

Phase 2/3

1

Phase 2

2

Phase 1/2

1

Active Trials

NCT ID	Title	Condition	Status
Phase 3
NCT03020030	Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Children and Adolescents	Acute Lymphoblastic Leukemia, Pediatric	Active, Not Recruiting
Phase 2/3
NCT07072585	Testing the Addition of Daratumumab to Chemotherapy for Treating Patients With…	Stage II T Lymphoblastic Leukemia/Lymphoma	Not Yet Recruiting
Phase 2
NCT00501826	Combination Chemotherapy and Nelarabine in Treating Patients With T-cell Acute…	T Acute Lymphoblastic Leukemia	Recruiting
NCT06390319	Adding Dasatinib Or Venetoclax To Improve Responses In Children With Newly Diagnosed…	T-cell Acute Lymphoblastic Leukemia	Recruiting
Phase 1/2
NCT07294677	CApivasertib, Venetoclax And Low-intensity chemotheRapY for Adults With ALL/LBL	Leukemia	Recruiting

Sponsors Running Nelarabine Trials

M.D. Anderson Cancer Center (1) Dana-Farber Cancer Institute (1) St. Jude Children's Research Hospital (1) Children's Oncology Group (1) University of Chicago (1)

Disease Areas

Get alerts when Nelarabine trials change

Status changes, date slips, and new filings — detected daily, delivered to your inbox.

Nelarabine Clinical Trials